R. Kalluri et al., IDENTIFICATION OF THE ALPHA-3 CHAIN OF TYPE-IV COLLAGEN AS THE COMMONAUTOANTIGEN IN ANTIBASEMENT MEMBRANE DISEASE AND GOODPASTURE-SYNDROME, Journal of the American Society of Nephrology, 6(4), 1995, pp. 1178-1185
Antiglomerular basement membrane (GEM) antibodies can cause glomerulon
ephritis or pulmonary hemorrhage by themselves or Goodpasture syndrome
when they occur together. It is unknown if variations in antibody rea
ctivity contribute to the different patterns of organ involvement seen
in this disease. This study examines the reactivity of the alpha 1-al
pha 6 NCl domains of Type IV collagen, the putative autoantigen, in se
ra from patients with anti-GEM antibodies after various clinical prese
ntations of lung hemorrhage and renal injury. Serum or plasma containi
ng anti-GEM antibodies from 35 patients with combined glomerulonephrit
is and pulmonary hemorrhage, 19 with glomerulonephritis alone, and 4 w
ith pulmonary hemorrhage alone were compared with samples from 19 norm
al controls and 32 patients with other kidney diseases. Four different
immunologic assays were performed with bovine alpha 1-alpha 6(IV) and
recombinant human type alpha 1-alpha 5(IV) collagen NCl domains. The
study found that the anti-GEM antibodies from all patients reacted wit
h the alpha 3(IV) NCl (85% exclusively). Additional limited reactivity
with the alpha 1(IV) NCl and alpha 4(IV) NCl was found in 15 and 3%,
respectively. This non-alpha 3(IV) NCl reactivity was most frequent in
the patients with anti-GBM antibodies and glomerulonephritis alone. N
one of the patients had reactivity to other basement membrane componen
ts like laminin, fibronectin, heparan sulfate proteoglycan, entactin,
or the 7S and triple helical fragments of Type IV collagen. The observ
ed alpha-chain NCl reactivity was confined to patients with anti-GEM a
ntibodies with no additional reactivities detected among a large numbe
r of other kidney diseases controls, The correlation of alpha 1-alpha
6(1V) NCl reactivity in a large number of patients with anti-GEM antib
odies defined by classic assays definitively establishes that reactivi
ty to alpha 3(IV) NCl domains is both sufficient and necessary for the
expression of autoimmune disease directed to the NCl domain of Type I
V collagen. On the basis of the evidence, the classification of antiba
sement membrane disease and Goodpasture syndrome as anti-Type IV colla
gen disease is proposed.